Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

RON (MST1R) is a novel prognostic marker and therapeutic target for gastroesophageal adenocarcinoma.

Cancer biology & therapy - 1 Jul 2011

Catenacci Daniel V T, Cervantes Gustavo, Yala Soheil, Nelson Erik A, El-Hashani Essam, Kanteti Rajani, El Dinali Mohamed, Hasina Rifat, Brägelmann Johannes, Seiwert Tanguy, Sanicola Michele, Henderson Les, Grushko Tatyana A, Olopade Olufunmilayo, Karrison Theodore, Bang Yung-Jue, Kim Woo Ho, Tretiakova Maria, Vokes Everett, Frank David A, Kindler Hedy L, Huet Heather, Salgia Ravi

Abstract excerpt

RON (MST1R) is one of two members of the MET receptor tyrosine kinase family, along with parent receptor MET. RON has a putative role in several cancers, but its expression and function is poorly characterized in gastroesophageal adenocarcinoma. A recognized functional role of MET tyrosine kinase...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Esophageal Neoplasms
Share to Hepatocyte Growth Factor

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Piperazines

Share to Proto-Oncogene Proteins c-met

Share to Receptor, ErbB-2

Share to Receptors, Growth Factor

Share to STAT3 Transcription Factor

Share to Sulfonamides

Source

Open in PubMed Open full text

Identifiers

PMID: 21543897
DOI: 10.4161/cbt.12.1.15747
PMCID: PMC3149873

Genes

MET
STAT3
ERBB2

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-21543897-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

RON (MST1R) is a novel prognostic marker and therapeutic target for gastroesophageal adenocarcinoma.PMID 21543897Read ↗

An Introduction and Overview of RON Receptor Tyrosine Kinase SignalingSemantic proximity Read ↗

From Concept to Reality: The Long Road to c-Met and RON Receptor Tyrosine Kinase Inhibitors for the Treatment of CancerSemantic proximity Read ↗

MET tyrosine kinase receptor expression and amplification as prognostic biomarkers of survival in gastroesophageal adenocarcinomaSemantic proximity Read ↗

Pathogenesis of RON receptor tyrosine kinase in cancer cells: activation mechanism, functional crosstalk, and signaling addictionSemantic proximity Read ↗

The RON and MET oncogenes are co-expressed in human ovarian carcinomas and cooperate in activating invasivenessSemantic proximity Read ↗

Oncogenesis of RON receptor tyrosine kinase: a molecular target for malignant epithelial cancers.Semantic proximity Read ↗

Targeting MET Dysregulation in CancerSemantic proximity Read ↗

Ror1 Is a Pseudokinase That Is Crucial for Met-Driven TumorigenesisSemantic proximity Read ↗

Role of c-MET in upper aerodigestive malignancies--from biology to novel therapies.Semantic proximity Read ↗

Activation of the RON receptor tyrosine kinase attenuates transforming growth factor-beta1-induced apoptotic death and promotes phenotypic changes in mouse intestinal epithelial cells.Semantic proximity Read ↗

Function of the c-Met receptor tyrosine kinase in carcinogenesis and associated therapeutic opportunitiesSemantic proximity Read ↗

Targeting MET amplification in Gastro-oesophageal (GO) malignancies and overcoming MET inhibitor resistance: challenges and opportunities.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.